Get started
PFIZER INCPFIZER INCPFIZER INC

PFIZER INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

PFE trade ideas

Ex-dividend date - An end to investors' hesitation?Good evening. Price has remained awfully quiet in anticipation of bad headlines. When those headlines actually arrived (23 elderly patients dead in Norway), they were swept under the rug by media world-wide, or just shrugged off. Source: Bloomberg - Pfizer Vaccine Safe for Elderly Despite Norway Scare, WHO Says Price has remained extremely stable around 36.22-37.78$ but the ex-dividend date is 28th of January, which means if investors were looking to buy but were hesitant, they'll have to pull the trigger in the coming 2 days or miss out on the dividends of the quarter. Q4 2020 Earnings report is expected on the 2nd of February. Might be exactly what PFE needs to break out towards 42.50$ again. Especially considering the company's pledge to make 1.3 to 2 billion doses in 2021. P.S.: Pfizer is looking at a 50% COVID vaccine earnings split with BioNTech, or even slightly more. Source: Motley Fool - What Does 2021 Hold for BioNTech Stock?
NYSE:PFELong
by Conda400
1
BUY $PFE - NRPicks Ene 17Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. Pfizer mainly sells prescription drugs and vaccines, also spends a leading amount on research and development, close to $8 billion annually. The company has developed its COVID-19 vaccine, however, it has not reflected its optimism in the stock price. The company has generated the same income quarter by quarter during the year, so we can see a good future for the development of its vaccine and the development of the new strain of the virus. Fundamentals: - Value - P/B 3.1x VS 4.3x Industry - ROE 22% vs. 17% industry Technicians: - Price level below SMA 250-200-150 - Williams R% at -50% levels - RSI (40) Midlevel - +1% average upside during the month As a result of the allergic reactions to the vaccine presented, PFE presented a 15% correction from December 8 to December 31, which stopped at a support of $36.3. From this point on, the stock presented a change in trend, which could continue due to the fact that the stock is below its medium term moving average.
NYSE:PFELong
by NewroadTrader
Pfizer Inc. Ready to Launch The Rocket 🚀🚀🚀💡 Trade Idea 📈 Buy Limit Pfizer Inc. @ 36.70 🎯 Target Profit 43.08 🛑 Stop Loss 34.80 ❌ Do not risk more than 1 % of your account on each trade 🙂 Good Luck ! Description: The price was ranging inside a parallel channel near a confluence zone between the daily support and the 61.8% Fibonacci retracement. We have a low volume, but our expectation that it will increase, and this will lead to a breakout of the channel to the upside, and then a huge move to the 43.08 mark. ------------------------------------------------------------------------------------- Please press “Like” if you appreciate the trading idea 👍 “Follow” for more trading ideas in the future 👀 “Comment” below to share your thoughts with us and other traders 👥 ------------------------------------------------------------------------------------- Risk Disclaimer: All trading ideas published by collegeofpips are for educational purposes only. These posts can help you to enhance your trading skills, but please do your own research before opening any trading position. ⚠️
NYSE:PFELong
by CollegeofPips
16